In an effort to support patients who may be indirectly affected by COVID-19, Medtronic recently announced a donation program for the IN.PACT™ AV Drug Coated Balloon for Arteriovenous Access Maintenance in patients with end stage renal disease (ESRD). ESRD patients undergoing regular hemodialysis, which has been deemed an essential procedure during the pandemic, are at high risk for exposure to and complications from COVID-19.
In the IN.PACT AV Access Trial, IN.PACT AV demonstrated a 56% reduction in fistula reinterventions vs. PTA at six months1, offering a unique clinical benefit. Medtronic hopes this donation program will help extend the time to reintervention, thereby limiting the time ESRD patients are in the hospital.
U.S. sites affected by COVID-19 and performing AV access maintenance procedures may submit IN.PACT AV product donation requests via the Medtronic Giving Connection. Medtronic will donate up to $10 million in product, with each request fulfilled using a standardized 10-unit kit.
1. Results from the IN.PACT™ AV Access Clinical Trial found in the IN.PACT™ AV drug-coated balloon (DCB) Instructions For Use (IFU).